Private Equity 3 Hours

Last updated: August 14, 2026, 11:35 AM ET

Private Equity Dealmaking and Strategy

Private equity firms are actively pursuing diverse investment strategies, from distressed debt to niche sectors. Pimco and Pollen Street are reportedly among the suitors for a €1.2bn ($1.4bn) non-performing loan portfolio being divested by Italy's BFF Bank. Meanwhile, Butterfly, Graham, and Wise Equity are showing interest in nutraceutical assets, while Astorg is nearing a $1bn carve-out of Thermo Fisher's microbiology business, driven by demand for antimicrobial testing.

Investor Relations and Growth

Institutional investors are also shaping the private equity landscape. The Weymouth Retirement Board has issued a request for proposals for private equity co-investment managers. In the realm of GP stakes, Hollyport has partnered with Blue Owl, a move that its chief executive anticipates will foster significant growth.

Global Expansion and Capital Allocation

Global expansion is also on the agenda, with UK spinout investor Northern Gritstone set to open an office in San Francisco. On a larger scale, Saudi Arabia's Public Investment Fund (PIF) is pivoting its strategy towards value realization and increasing the involvement of private capital for its next phase of development through 2030. Furthermore, Mistral has secured backing from entities including ASML and Amadeus for its data center expansion plans.